Kara N. Maxwell

6.1k total citations · 1 hit paper
89 papers, 2.9k citations indexed

About

Kara N. Maxwell is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Kara N. Maxwell has authored 89 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 32 papers in Genetics and 31 papers in Cancer Research. Recurrent topics in Kara N. Maxwell's work include Cancer Genomics and Diagnostics (27 papers), BRCA gene mutations in cancer (26 papers) and Cancer-related Molecular Pathways (15 papers). Kara N. Maxwell is often cited by papers focused on Cancer Genomics and Diagnostics (27 papers), BRCA gene mutations in cancer (26 papers) and Cancer-related Molecular Pathways (15 papers). Kara N. Maxwell collaborates with scholars based in United States, Canada and Australia. Kara N. Maxwell's co-authors include Jan L. Breslow, Edward A. Fisher, Raymond E. Soccio, Susan M. Domchek, Elizabeth M. Duncan, Ephraim Sehayek, Katherine L. Nathanson, J.O. White, Kevin O‘Connell and Ina N. Cholst and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Kara N. Maxwell

78 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype

2004 502 citations Kara N. Maxwell, Jan L. Breslow profile →

Peers

Countries citing papers authored by Kara N. Maxwell

Since Specialization

Citations

This map shows the geographic impact of Kara N. Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara N. Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara N. Maxwell more than expected).

Fields of papers citing papers by Kara N. Maxwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kara N. Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara N. Maxwell. The network helps show where Kara N. Maxwell may publish in the future.

Co-authorship network of co-authors of Kara N. Maxwell

This figure shows the co-authorship network connecting the top 25 collaborators of Kara N. Maxwell. A scholar is included among the top collaborators of Kara N. Maxwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara N. Maxwell. Kara N. Maxwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration 2025 ·Cancer ·(unknown), (unknown), Adrian J. Bailey, Lorna Kwan, (unknown), Jeremy B. Shelton, Michael Lewis, David O. Beenhouwer, Karim Chamie, Brent S. Rose, Kara N. Maxwell, Nicholas G. Nickols, Kosj Yamoah, Michael J. Kelley, Timothy R. Rebbeck, Martin W. Schoen, Matthew B. Rettig, Hari S. Iyer, Isla P. Garraway	0
2	TP53 variant clusters stratify phenotypic diversity in germline carriers and reveal an osteosarcoma-prone subgroup 2025 ·Nature Communications ·Nicholas W. Fischer, (unknown), (unknown), (unknown), (unknown), Noa Alon, Emilie Montellier, Pierre Hainaut, Kara N. Maxwell, Christian P. Kratz, Ran Kafri, David Malkin	0
3	Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent -rate method ideal for real-world analyses 2024 ·EBioMedicine ·Harshraj Leuva, Mengxi Zhou, (unknown), (unknown), Izak Faiena, (unknown), (unknown), Carol Luhrs, Kara N. Maxwell, Daniel D. Von Hoff, Susan E. Bates, Tito Fojo	2
4	Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents—To Test or not to Test? 2024 ·Clinical Cancer Research ·Christian P. Kratz, Philip J. Lupo, Kristin Zelley, Jaclyn Schienda, Kim E. Nichols, Douglas R. Stewart, David Malkin, Garrett M. Brodeur, Kara N. Maxwell, Sharon E. Plon, Michael F. Walsh	9
5	A phase II single-arm trial of niraparib in platinum-sensitive metastatic castration-resistant prostate cancer with DNA repair defects (PLATPARP). 2024 ·Journal of Clinical Oncology ·(unknown), Alexandra Torres, Joann M. Miller, Jennifer Louie, (unknown), Naomi B. Haas, Samuel U Takvorian, Kara N. Maxwell, Susan M. Domchek, Vivek Narayan	1
6	Prostate screening for men with inherited risk of developing aggressive prostate cancer: The PATROL study. 2024 ·Journal of Clinical Oncology ·Heather H. Cheng, (unknown), (unknown), (unknown), Daniel J. Lee, Michael A. Liss, Kara N. Maxwell, Lisa F. Newcomb, Yaw A. Nyame, Sarah P. Psutka, Alexandra Sokolova, Erika M. Wolff, Jonathan L. Wright, Daniel W. Lin	0
7	Identification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalence 2024 ·JNCI Journal of the National Cancer Institute ·Minjie Luo, Derek Wong, Kristin Zelley, Jinhua Wu, (unknown), Elizabeth H. Denenberg, Elizabeth A. Fanning, Jiani Chen, (unknown), Netta Golenberg, (unknown), Laura K. Conlin, Kara N. Maxwell, Gerald Wertheim, Lea F. Surrey, Yiming Zhong, Garrett M. Brodeur, Suzanne P. MacFarland, Marilyn M. Li	2
8	Rates of Intervention and Cancer Detection on Initial versus Subsequent Whole-body MRI Screening in Li-Fraumeni Syndrome 2023 ·Cancer Prevention Research ·(unknown), (unknown), (unknown), Anh N. Le, (unknown), (unknown), (unknown), Jacquelyn Powers, Kristin Zelley, Lisa J. States, (unknown), Bryson W. Katona, Suzanne P. MacFarland, Kara N. Maxwell	3
9	Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans 2023 ·The Oncologist ·Luca Valle, Nicholas G. Nickols, Ryan Hausler, Patrick R. Alba, Tori Anglin-Foote, Cristina Díaz-Agero Pérez, Kosj Yamoah, Brent S. Rose, Michael J. Kelley, Scott L. DuVall, Isla P. Garraway, Kara N. Maxwell, Julie A. Lynch	5
10	Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood 2022 ·Clinical Genetics ·Kara N. Maxwell, Vishal Patel, Kevin T. Nead, Shana L. Merrill, Dana Clark, Qinqin Jiang, Bradley Wubbenhorst, Kurt D’Andrea, Roger B. Cohen, Susan M. Domchek, Jennifer J.D. Morrissette, Roger A. Greenberg, Daria V. Babushok, Katherine L. Nathanson	3
11	PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer 2022 ·JCO Precision Oncology ·Adam Kraya, Kara N. Maxwell, Monika A. Eiva, Bradley Wubbenhorst, John Pluta, Michael D. Feldman, Anupma Nayak, Daniel J. Powell, Susan M. Domchek, Robert H. Vonderheide, Katherine L. Nathanson	9
12	Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers 2022 ·Nature Communications ·Jennifer Shah, Dana Pueschl, Bradley Wubbenhorst, (unknown), John Pluta, Kurt D’Andrea, (unknown), (unknown), Wenting Zhou, Adam Kraya, (unknown), (unknown), Violeta Serra, Judith Balmañà, Michael D. Feldman, Patrice J. Morin, Anupma Nayak, Kara N. Maxwell, Susan M. Domchek, Katherine L. Nathanson	14
13	A Natural Language Processing–Assisted Extraction System for Gleason Scores: Development and Usability Study 2021 ·JMIR Cancer ·Shun Yu, Anh N. Le, Emily Feld, Emily Schriver, Peter Gabriel, Abigail Doucette, Vivek Narayan, Michael D. Feldman, Lauren E. Schwartz, Kara N. Maxwell, Danielle L. Mowery	7
14	Rates of COVID-19–Related Outcomes in Cancer Compared With Noncancer Patients 2020 ·JNCI Cancer Spectrum ·Lova Sun, (unknown), Anh N. Le, (unknown), Abigail Doucette, Peter Gabriel, Marylyn D. Ritchie, Daniel J. Rader, Ivan Maillard, Erin M. Bange, Alexander C. Huang, Robert H. Vonderheide, Angela DeMichele, Anurag Verma, Ronac Mamtani, Kara N. Maxwell	27
15	Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer 2019 ·Clinical Cancer Research ·Adam Kraya, Kara N. Maxwell, Bradley Wubbenhorst, Brandon M. Wenz, John Pluta, Andrew J. Rech, Liza M. Dorfman, (unknown), (unknown), Nandita Mitra, Jennifer J.D. Morrissette, Michael D. Feldman, Anupma Nayak, Susan M. Domchek, Robert H. Vonderheide, Katherine L. Nathanson	57
16	Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing 2015 ·Genetics in Medicine ·Angela R. Bradbury, Linda Patrick‐Miller, Brian L. Egleston, Laura DiGiovanni, Jamie Brower, Diana Harris, (unknown), Kara N. Maxwell, (unknown), (unknown), Amanda Brandt, Jessica M. Long, Jacquelyn Powers, Jill E. Stopfer, Katherine L. Nathanson, Susan M. Domchek	46
17	Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer 2014 ·Genetics in Medicine ·Kara N. Maxwell, Bradley Wubbenhorst, Kurt D’Andrea, Bradley Garman, Jessica M. Long, Jacquelyn Powers, (unknown), Jill E. Stopfer, Jiajun Zhu, Angela R. Bradbury, Michael S. Simon, Angela DeMichele, Susan M. Domchek, Katherine L. Nathanson	106
18	Differential Gene Regulation of StarD4 and StarD5 Cholesterol Transfer Proteins 2005 ·Journal of Biological Chemistry ·Raymond E. Soccio, Rachel M. Adams, Kara N. Maxwell, Jan L. Breslow	95
19	The spd-2 gene is required for polarization of the anteroposterior axis and formation of the sperm asters in the Caenorhabditis elegans zygote 2000 ·Developmental Biology ·Kevin O‘Connell, Kara N. Maxwell, J.O. White	130
20	Hypersensitivity lung disease in the turkey raising industry. 1974 ·PubMed ·R S Boyer, (unknown), (unknown), (unknown), Kara N. Maxwell, Renee M. Gardner, Attilio D. Renzetti	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact